The Company is a research-based pharmaceutical company focused on discovering, developing and commercializing differentiated products that address unmet medical needs, and are prescribed principally by primary care physicians.
The best Bull and Bear pitches based on recency and number of recommendations.
Pipeline doesn't hold any blockbuster candidates, expenses are high, and their flagship products are not doing as well as hoped. Xopenex is under price pressure, and Lunesta is running up against generic versions of Ambien.
Read the most recent pitches from players about SEPR.DL.
Find the members with the highest scoring picks in SEPR.DL.
See what the Wall Street professionals think, according to their public statements and filings.